The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C05 | Vasoprotectives | |
| 3 | C05B | Antivaricose therapy | |
| 4 | C05BB | Sclerosing agents for local injection | |
| 5 | C05BB02 | Polidocanol |
| Active Ingredient | Description | |
|---|---|---|
| Polidocanol |
Polidocanol has a concentration-dependent and volume-dependent damaging effect on the endothelium of blood vessels. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| AETHOXYSKLEROL Solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
